REN Pharmaceuticals
Latest round
- Series A
Last raised
- Jun 2008
Total raised
- $6.3M
Investors
- 4
About REN Pharmaceuticals
Founded in 2008 and based in New York, US, REN Pharmaceuticals, Inc. operates as a biotechnology company that provides therapies for the treatment of kidney and cardiovascular diseases.
Who invested in REN Pharmaceuticals
4 investors across 2 rounds
See all investors in REN Pharmaceuticals
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about REN Pharmaceuticals
Who invested in REN Pharmaceuticals?
REN Pharmaceuticals has 4 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has REN Pharmaceuticals raised?
REN Pharmaceuticals has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did REN Pharmaceuticals last raise money?
REN Pharmaceuticals's most recent round on record is a Series A, in Jun 2008.
What does REN Pharmaceuticals do?
Founded in 2008 and based in New York, US, REN Pharmaceuticals, Inc.
Where is REN Pharmaceuticals headquartered?
REN Pharmaceuticals is headquartered in New Haven, US.
Which VCs invest in companies like REN Pharmaceuticals?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at REN Pharmaceuticals's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like REN Pharmaceuticals? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.